INSIGHTS ON CLINICAL TRIAL DESIGN

  • The Complex Issues With Developing A Novel Human Antibody From Scratch
    The Complex Issues With Developing A Novel Human Antibody From Scratch

    Having the right specialists on their team enables Premier Research to recruit subjects relatively quickly, despite extremely complex selection criteria for this multiple myeloma clinical trial. In addition, maintaining a close and cooperative customer relationship assisted in moving the study forward.

  • Complete Response: Lymphoma Trial A Success For Five Patients
    Complete Response: Lymphoma Trial A Success For Five Patients

    A trans-Atlantic study to evaluate an antibody for treatment of B-cell non-Hodgkins lymphoma overcame patient recruiting challenges and has already succeeded beyond expectations in the form of five patients declared disease-free a year and counting while still three years from completing patient follow-up.

  • The Importance Of Advocating For Female Participation In Clinical Trials
    The Importance Of Advocating For Female Participation In Clinical Trials

    For decades, drugs were approved without being tested on women or factoring in whether women would have different reactions or require different dosages than men. Attitudes around involving women in clinical trials have evolved significantly in the past 25 years, however, despite new expectations from regulators pushing for women to be involved in studies, parity has yet to be achieved.

  • Top 3 Reasons Why A Direct-To-Patient Clinical Trial is Right For You
    Top 3 Reasons Why A Direct-To-Patient Clinical Trial is Right For You

    Patient-centricity has been a growing trend across the pharmaceutical and biotech industries for some time now. As the focus on precision and personalized medicine continues to increase, sponsors are looking for innovative ways to increase patient enrollment and compliance while reducing drug development timelines and costs. The direct-to-patient (DTP) model has emerged as a potential solution. This model illustrates a means by which a patient is able to receive his or her medication in the convenience of their home. In this article, we’ll share the top three challenges many sponsors face, and how a direct-to-patient pharmacy can provide solutions.

More Insights On Clinical Trial Design

CLINICAL TRIAL DESIGN SOLUTIONS

  • Speed to Study Brochure

    Speed to Study™ accelerates your  trial while maximizing flexibility so you can get the data you need faster. 

  • Biorasi’s Center Of Excellence: Neurology And Regenerative Medicine
    Biorasi’s Center Of Excellence: Neurology And Regenerative Medicine

    Biorasi’s Neurology and Regenerative Medicine Center of Excellence has become a leader in this evolving field. Our expert team, combined with Biorasi’s close relationship with sites worldwide and access to diverse and hard-to-find patient populations, allow us to guide neurology, pain, psychiatric, and cell therapy trials to success.

  • Rideshare Integration

    The only solution that offers both ride and reimbursement automation within one portal.

  • Quantitative Pharmacology and Pharmacometrics
    Quantitative Pharmacology and Pharmacometrics

    Exposure (and Dose) Response Analyses, including pharmacokinetic and pharmacodynamics analyses, guide critical decisions in drug development. Cytel’s expert Quantitative Pharmacology and Pharmacometrics group delivers high quality solutions to help our customers get those decisions right.

  • Distribution Services
    Distribution Services

    When time-reduction, cost-savings, quality and reliability matter, ropack pharma solutions is the distribution partner positioned to deliver.

More Clinical Trial Design Solutions